scholarly journals Radium-223 (Ra-223) Re-treatment (Re-tx): First Experience From an International, Multicenter, Prospective Study in Patients (Pts) With Castration-Resistant Prostate Cancer and Bone Metastases (mCRPC)

2016 ◽  
Vol 27 ◽  
pp. iv30
Author(s):  
G. Procopio ◽  
S. Severi ◽  
E. Verzoni ◽  
M. Sansovini ◽  
O. Sartor ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Prospective Study ◽  
Bone Metastases ◽  
Castration Resistant Prostate Cancer ◽  
Castration Resistant ◽  
Radium 223 ◽  
Multicenter Prospective Study ◽  
International Multicenter

scholarly journals Re‐treatment with radium‐223: 2‐year follow‐up from an international, open‐label, phase 1/2 study in patients with castration‐resistant prostate cancer and bone metastases

The Prostate ◽  
2019 ◽  
Vol 79 (14) ◽  
pp. 1683-1691 ◽  
Author(s):  
Oliver Sartor ◽  
Daniel Heinrich ◽  
Neil Mariados ◽  
Maria José Méndez Vidal ◽  
Daniel Keizman ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Bone Metastases ◽  
Phase 1 ◽  
Castration Resistant Prostate Cancer ◽  
Open Label ◽  
Castration Resistant ◽  
Radium 223 ◽  
Open Label Phase

scholarly journals Radium-223 in combination with docetaxel in patients with castration-resistant prostate cancer and bone metastases: a phase 1 dose escalation/randomised phase 2a trial

2019 ◽  
Vol 114 ◽  
pp. 107-116 ◽  
Author(s):  
Michael J. Morris ◽  
Yohann Loriot ◽  
Christopher J. Sweeney ◽  
Karim Fizazi ◽  
Charles J. Ryan ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Bone Metastases ◽  
Dose Escalation ◽  
Phase 1 ◽  
Castration Resistant Prostate Cancer ◽  
Castration Resistant ◽  
Radium 223
Sign in / Sign up

Export Citation Format

Share Document